Notch-driven Carcinogenesis: the Merging of Hepatocellular Cancer and Cholangiocarcinoma into a Common Molecular Liver Cancer Subtype

Overview

Journal J Hepatol

Publisher Elsevier

Specialty Gastroenterology

Date 2013 Jan 29

PMID 23352938

Citations 19

Authors

Nataliya Razumilava

Gregory J Gores

Affiliations

Soon will be listed here.

Citing Articles

Hepatocellular carcinoma: signaling pathways and therapeutic advances.

Zheng J, Wang S, Xia L, Sun Z, Chan K, Bernards R Signal Transduct Target Ther. 2025; 10(1):35.

PMID: 39915447 PMC: 11802921. DOI: 10.1038/s41392-024-02075-w.

Signaling pathways in liver cancer: pathogenesis and targeted therapy.

Xue Y, Ruan Y, Wang Y, Xiao P, Xu J Mol Biomed. 2024; 5(1):20.

PMID: 38816668 PMC: 11139849. DOI: 10.1186/s43556-024-00184-0.

The role of Hedgehog and Notch signaling pathway in cancer.

Xia R, Xu M, Yang J, Ma X Mol Biomed. 2022; 3(1):44.

PMID: 36517618 PMC: 9751255. DOI: 10.1186/s43556-022-00099-8.

LY450139 Inhibited Ti-Particle-Induced Bone Dissolution via Suppressing Notch and NF-κB Signaling Pathways.

Gao J, Wu P, Chi Y, Xu H, Zhao Y, Song N Calcif Tissue Int. 2022; 111(2):211-223.

PMID: 35588014 PMC: 9300553. DOI: 10.1007/s00223-022-00980-2.

Notch signaling pathway: architecture, disease, and therapeutics.

Zhou B, Lin W, Long Y, Yang Y, Zhang H, Wu K Signal Transduct Target Ther. 2022; 7(1):95.

PMID: 35332121 PMC: 8948217. DOI: 10.1038/s41392-022-00934-y.

References

Villanueva A, Alsinet C, Yanger K, Hoshida Y, Zong Y, Toffanin S . Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice. Gastroenterology. 2012; 143(6):1660-1669.e7. PMC: 3505826. DOI: 10.1053/j.gastro.2012.09.002. View

Fan B, Malato Y, Calvisi D, Naqvi S, Razumilava N, Ribback S . Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest. 2012; 122(8):2911-5. PMC: 3408746. DOI: 10.1172/JCI63212. View

Weng A, Ferrando A, Lee W, Morris 4th J, Silverman L, Sanchez-Irizarry C . Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004; 306(5694):269-71. DOI: 10.1126/science.1102160. View

Boulter L, Govaere O, Bird T, Radulescu S, Ramachandran P, Pellicoro A . Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med. 2012; 18(4):572-9. PMC: 3364717. DOI: 10.1038/nm.2667. View

Viatour P, Ehmer U, Saddic L, Dorrell C, Andersen J, Lin C . Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway. J Exp Med. 2011; 208(10):1963-76. PMC: 3182062. DOI: 10.1084/jem.20110198. View

Delous M, Yin C, Shin D, Ninov N, Carten J, Pan L . Sox9b is a key regulator of pancreaticobiliary ductal system development. PLoS Genet. 2012; 8(6):e1002754. PMC: 3375260. DOI: 10.1371/journal.pgen.1002754. View

Strazzabosco M, Fabris L . Notch signaling in hepatocellular carcinoma: guilty in association!. Gastroenterology. 2012; 143(6):1430-4. PMC: 3583012. DOI: 10.1053/j.gastro.2012.10.025. View

Fortini M . Notch signaling: the core pathway and its posttranslational regulation. Dev Cell. 2009; 16(5):633-47. DOI: 10.1016/j.devcel.2009.03.010. View

Sekiya S, Suzuki A . Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes. J Clin Invest. 2012; 122(11):3914-8. PMC: 3484442. DOI: 10.1172/JCI63065. View

10.

Cantarini M, de la Monte S, Pang M, Tong M, DErrico A, Trevisani F . Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology. 2006; 44(2):446-57. DOI: 10.1002/hep.21272. View

11.

Wang C, Qi R, Li N, Wang Z, An H, Zhang Q . Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression. J Biol Chem. 2009; 284(24):16183-16190. PMC: 2713568. DOI: 10.1074/jbc.M109.002105. View